Ocera Therapeutics Inc Stock

Stocks

17-11-02	Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Ocera Therapeutics, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
17-10-20	Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®	GL
17-08-23	Ocera Therapeutics Selected to Present an Oral Presentation and Three Posters on OCR-002 at the AASLD Liver Meeting® 2017	GL
17-08-01	Ocera Therapeutics Reports Second Quarter 2017 Financial Results	GL
17-06-01	Ocera Initiates Phase 2a Study with Oral OCR-002 in Patients with Cirrhosis	GL

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
OCERA THERAPEUTICS INC	-.--%	+2.29%	-	-	0
REGENERON PHARMACEUTICALS, INC.	-1.05%	-2.97%	+14.99%	-8.68%	66.75B
UCB	+0.09%	-6.47%	+36.26%	+190.17%	50.65B
SAMSUNG BIOLOGICS CO.,LTD.	-2.29%	+36.80%	+36.80%	+36.80%	42.55B
CSL LIMITED	-0.98%	-2.05%	-51.43%	-52.96%	41.15B
BIOGEN INC.	-8.17%	-6.68%	+44.20%	-31.18%	28.34B
MODERNA, INC.	+0.64%	-15.46%	+105.17%	-44.43%	26.76B
INCYTE CORPORATION	+0.57%	-2.69%	+64.16%	+86.01%	22.95B
INNOVENT BIOLOGICS, INC.	+7.77%	+12.59%	+12.98%	+208.10%	20B
BRIDGEBIO PHARMA, INC.	+1.22%	+7.93%	+76.33%	+361.53%	16.48B
Average	-0.31%	-2.83%	+37.72%	+82.82%	35.07B
Weighted average by Cap.	-0.81%	-3.51%	+29.60%	+58.49%

Employees

Sector